Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Filings indexed 968 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Press_release.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of first-quarter 2026 financial results for ArcticZymes Technologies, including sales growth, EBITDA figures, segment performance, CEO commentary, and outlook. It contains specific quarterly financial data and analysis, such as revenue, EBITDA, and segment breakdowns, which are characteristic of an Interim / Quarterly Report. The presence of a webcast presentation announcement does not change the nature of the document, which is a comprehensive quarterly financial report. The document length (4817 characters) is sufficient to contain substantive financial data, not just a brief announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 Norwegian
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Presentation.pdf
Call Transcript Classification · 95% confidence The document is a detailed presentation covering Q1 2026 financial performance, commercial updates, strategic priorities, and operational highlights. It includes financial figures such as revenue, EBITDA, sales breakdown, and cash flow, as well as strategic and commercial commentary. The presence of a Q&A section and the format resembling slides with agenda points and speaker names (CEO, CFO, CCO) strongly indicate this is a transcript or presentation from a quarterly earnings call or investor update. It is not a full annual or interim report, nor an audit or regulatory filing. It is not merely an announcement or a short summary but a comprehensive presentation of quarterly results and outlook. Therefore, the document best fits the category of a Call Transcript (CT).
2026-05-07 Norwegian
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Report.pdf
Regulatory Filings
2026-05-07 Norwegian
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of first-quarter 2026 financial results for ArcticZymes Technologies, including sales growth, EBITDA, segment performance, CEO commentary, and outlook. It contains substantive financial data and analysis for a period shorter than a full fiscal year (Q1 2026). The presence of actual financial figures and business segment details indicates this is a comprehensive quarterly financial report rather than a brief earnings highlight or a presentation. The document also mentions a webcast presentation but is itself the financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 Norwegian
ArcticZymes Technologies ASA: Notice of Annual General Meeting - Attachment: Notice_of_AGM_2026.pdf
AGM Information Classification · 95% confidence The document is a detailed notice and agenda for the Annual General Meeting (AGM) of ArcticZymes Technologies ASA, including proposed resolutions on remuneration, corporate governance, approval of the annual report and financial statements for 2025, auditor's remuneration, and authorisations for share issuance and buyback. It includes both Norwegian and English text, typical for an AGM notice. The document does not contain the actual annual report or financial statements but refers to them being available on the company's website. It also includes proposals for shareholder votes and procedural details for the meeting. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. The document is lengthy (15,000 characters) and substantive, consistent with an AGM notice and agenda rather than a brief announcement or proxy solicitation. Therefore, the correct classification is AGM Information (AGM-R).
2026-05-06 Norwegian
ArcticZymes Technologies ASA: Notice of Annual General Meeting
AGM Information Classification · 100% confidence The document is a notice announcing the upcoming Annual General Meeting (AGM) of ArcticZymes Technologies ASA, including the date, time, and participation details. It explicitly states it is a 'Notice of Annual General Meeting' and provides information on registration and agenda availability. There is no financial data or report content, only an announcement of the meeting itself. Therefore, it fits the category of AGM Information (AGM-R). The document length is short and it serves as a meeting notice, not a report or results announcement.
2026-05-06 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.